[1]
|
S. M. Albelda, “Role of Integrins and Other Cell Adhesion Molecules in Tumor Progression and Metastasis,” Laboratory Investigation, Vol. 68, No. 1, 1993, pp. 4-17.
|
[2]
|
N. Takigawa, Y. Segawa, K. Manadai, I. Takata and N. Fujimoto, “Serum CD44 Levels in Patients with Non-Small Cell Lung Cancer and Their Relationship with Clinicophathological Features,” Lung Cancer, Vol. 18, No. 2, 1997, pp. 147-157.
doi:10.1016/S0169-5002(97)00060-3
|
[3]
|
H. A. Kargi, M. F. Kuyucuoglu, M. Alakavuklar, O. Akpinar and S. Erk, “CD44 Expression in Metastatic and Non-Metastatic Non-Small Cell Lung Cancers,” Cancer Letters, Vol. 119, No. 1, 1997, pp. 27-30.
doi:10.1016/S0304-3835(97)00254-1
|
[4]
|
T. Miyoshi, K. Knodo, N. Hino, T. Uyama and Y. Monden, “The Expression of the CD44 Variant Exon 6 Is Associated with Lymph Node Metastatis in Non-Small Cell Lung Cancer,” Clinic Cancer Research, Vol. 3, 1997, pp. 1289-1297.
|
[5]
|
C. F. Mountain, “A New International Staging System for Lung Cancer,” Chest, Vol. 89, No. 4, 1986, pp. 5225-5228.
|
[6]
|
X. M. Sun and G. P. Yi, “The Establishment of Researching Adhesive Molecules in Solid Tumors by Flow Cytometric Method,” Chinese Journal of Medical Laboratory Sciences, Vol. 20, 1997, pp. 9-11.
|
[7]
|
M. B. Penno, J. T. August, S. B. Baylin, M. Mabry, R. L. Linnoila, V. S. Lee, D. Croteau, X. L. Yang and C. Rosada, “Expression of CD44 in Human Lung Tumors,” Cancer Research, Vol. 54, 1994, pp. 1381-1387.
|
[8]
|
J. Lesley, R. Hyman and P. W. Kincade, “CD44 and Its Interactions with the Extracellular Matrix,” Advances in Immunology, Vol. 54, 1993, pp. 271-335.
doi:10.1016/S0065-2776(08)60537-4
|
[9]
|
D. Situ, H. Long, P. Lin, Z. Zhu, J. Wang, X. Zhang, Z. Xie and T. Rong, “Expression and Prognostic Relevance of CD44v6 in Stage I Non-Small Cell Lung Carcinoma,” Journal of Cancer Research and Clinic Oncology, Vol. 136, No. 8, 2010, pp. 1213-1219.
doi:10.1007/s00432-010-0771-5
|
[10]
|
A. S. Adhikari, N. Agarwal and T. Iwakuma, “Metastatic Potential of Tumor-Initiating Cells in Solid Tumors,” Front Biosciences, Vol. 16, 2011, pp. 1927-1938.
doi:10.2741/3831
|
[11]
|
M. Hofmann, W. Rudy, M. Zoller, C. Tolg, H. Ponta, P. Herrlich and U. Gunthert, “CD44 Splice Variants Confer Metastatic Behavior in Rats: Homologous Sequences Are Expressed in Human Tumor Cell Lines,” Cancer Research, Vol. 51, 1991, pp. 5292-5297.
|
[12]
|
P. Klingbeil, R. Marhaba, T. Jung, R. Kirmse, T. Ludwig and M. Zoller, “CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-Talk That Supports Adhesion and Apoptosis Resistance,” Molecular Cancer Research, Vol. 7, 2009, pp. 168-179.
doi:10.1158/1541-7786.MCR-08-0207
|
[13]
|
U. Valentiner, F. U. Valentiner and U. Schumacher, “Expression of CD44 Is Associated with a Metastatic Pattern of Human Neuroblastoma Cells in a SCID Mouse Xenograft Model,” Tumour Biolology, Vol. 29, No. 3, 2008, pp. 152-160. doi:10.1159/000143401
|
[14]
|
S. Riethdorf, H. Wikman and K. Pantel, “Review: Biological Relevance of Disseminated Tumor Cells in Cancer Patients,” International Journal of Cancer, Vol. 123, No. 9, 2008, pp. 1991-2006. doi:10.1002/ijc.23825
|